首页 正文

Clinical benefits, tolerability, and risk factors of adjuvant nivolumab for muscle-invasive bladder cancer

{{output}}
Background: In recent years, perioperative-sequential therapies have arisen for muscle-invasive bladder cancer (MIBC) treatment strategies. We are able to select more variable regimens for bladder cancer patients. This study aims... ...